Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing

Sean Conlan1, Pamela J Thomas2, Clayton Deming1

  • 1National Human Genome Research Institute, Bethesda, MD 20892, USA.

Insights

Carbapenem-resistant Enterobacteriaceae spread resistance via plasmids. This study found evidence of plasmid transfer between bacteria in the hospital environment, not within patients, and identified a new high-impact carbapenemase plasmid.

Area of Science:

  • Medical Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Carbapenem resistance in Enterobacteriaceae is a major public health concern.
  • Plasmid-mediated carbapenemase transfer can lead to untreatable healthcare-associated infections.

Purpose of the Study:

  • To investigate the diversity and mobility of carbapenemase-encoding plasmids.
  • To assess carbapenem-resistant Enterobacteriaceae in a hospital setting.

Main Methods:

  • Comprehensive surveillance and long-read genome sequencing of carbapenem-resistant Enterobacteriaceae.
  • Isolation of various Enterobacteriaceae species including Klebsiella pneumoniae, Escherichia coli, and Enterobacter cloacae.
  • Full end-to-end plasmid assembly and identification.

Main Results:

  • Identified diverse carbapenemase-encoding plasmids in multiple Enterobacteriaceae species.
  • Found evidence of horizontal plasmid transfer between bacterial species in the hospital environment.
  • Discovered a new, potentially high-impact carbapenemase plasmid present in unrelated patients and the environment.

Conclusions:

  • Plasmid transfer is more likely between bacteria in the hospital environment than within individual patients.
  • The identified new plasmid poses a significant clinical threat due to its wide distribution.
  • Genomic surveillance is crucial for understanding carbapenem resistance dynamics.